An interventional study of misoprostol in a neutral media and misoprostol in an acidic media in Labor Pain, sponsored by Aljazeera Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 20 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-05-19.
Sponsored by Aljazeera Hospital · Not applicable, Interventional, and Treatment
Misoprostol is a synthetic analogue of the naturally occurring prostaglandin E1. It was initially marketed for the treatment of peptic ulcers due to its mucosal protective and anti-secretory properties, but has commonly been used for the induction of abortion and labour .
Although initially having been established for oral use, misoprostol tablets are commonly used as vaginal suppositories for the previously purposes. Water or saline are frequently used in common practice to moisten the tablets prior to their administration, however, according to the pharmacokinetics of the drug, it should liquefy better in an acidic medium
396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.
This study's planned enrollment of 180 is above the median of 100 across 326 interventional studies indexed under Labor Pain.
Browse Labor Pain studies →Aljazeera Hospital is the lead sponsor of 63 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Intervention : misoprostol in a neutral media will be given to women to induce labour
Drug: misoprostol in a neutral media
Intervention : misoprostol in acidic media will be given to induce labour
Drug: misoprostol in an acidic media
Intervention : misoprostol in alkaline media will be given to induce labour
Drug: misoprostol in an alkaline media
giving misoprostol in a neutral media
Also known as: Drug (misoprostol + neutral media )
giving misoprostol in an acidic media
Also known as: Drug ( Misoprostol + acidic media )
giving misoprostol in an alkaline media
Also known as: Drug ( misoprostol + alkaline media )
The number of women who will start lactive phase of labour after treatment
the number of women in a group who will enter in active labour faster than other groups
Time frame: within 24 hours
This study is status unknown, as verified in May 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aljazeera Hospital